A Study on the Preference of Risperidone Dosage Forms

ConditionsSchizophrenia Bipolar Affective Disorder Autism Spectrum Disorder Conduct Disorder Mental Retardation

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorShanghai Mental Health Center

About this trial

This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.

Eligibility criteria

Qualifiers

Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study.

Disqualifiers

Have difficulty reading and understanding Chinese or refuse to participate in the study.

Trial design

Treatments tested in this trial

Not listed

Trial groups

1,000 Participants

are grouped into 1 trial group

Locations

Shanghai Mental Health Center200030, ShanghaiShanghai Municipality, China

Sponsors and collaborators

Shanghai Mental Health Center

Lead sponsor

Source ClinicalTrials.gov